Archives: Speakers

Olwyn Pentinga joined Tirlan in 2022 as the Category Manager for the Butterfat’s and Rennet Casein portfolios. Olwyn has spent over 10 years in the dairy industry, in various commercial roles across Asia Pacific and Europe having previously worked for Agropur and Glanbia Nutritional’s. She graduated from UCD with a degree in Commerce and Chinese.

Aamir Jaka leads Saama’s Customer Success team, which is focused on helping Saama customers achieve their business goals using Saama’s AI-driven SaaS platform, as well as product-based industry solutions and accelerators for customers.

He has over 20 years of experience in technology, consulting, and software organizations working to solve complex business challenges with technology-enabled, data-driven business insights. His ability to bridge technical and business topics within executive and end-user communities allows Aamir to work closely with Saama customers to drive digital transformation initiatives that generate measurable value-based outcomes.

Aamir joined Saama as part of the company’s 2019 acquisition of Comprehend Systems, Inc., where he led the Professional Services and Customer Success teams. Prior to Comprehend, Aamir led services and consulting teams at Adaptive Insights (a Workday company), Perficient and PwC.
A graduate of the University of Southern California, Aamir holds a BS in Business Information Systems and an MBA from the Haas School of Business at the University of California, Berkeley.

Sarah R Anderson is the US based Oncology Strategy Lead Director at Novotech. She is an executive clinical health professional with 20+ years of oncology drug development across all indications and phases including development and clinical operations delivery strategies, global project management and portfolio oversight.

Sara Bailey is an Oversight Director and Sr. Project Manager at PCM Trials with over 13 years of experience in clinical research, including operations at clinical research sites and decentralized clinical trials.

Solciris Dominguez is a Trial Project Director in the University of Pittsburgh for the Division of Rheumatology and Clinical Immunology, with a decade of experience in clinical research and clinical trials. She has organized, coordinated, and performed over 40 industry-sponsored and physician-initiated clinical trials. As well as, monitoring, identifying, selecting, and initiating investigational sites for clinical studies. She currently directs the MINT study, the first decentralized clinical trial of its kind in the nation at the University of Pittsburgh. Outside of work, Sol enjoys reading, exercising, spending time with family, and the beach.

Dr. Aggarwal is a professor of medicine at University of Pittsburgh and medical director of Arthritis and Autoimmunity Center at University of Pittsburgh Medical Center. He is the co-director of UPMC Myositis Center. His research and clinical areas of interest are clinical and translational research in inflammatory muscle diseases (myositis) and associated interstitial lung disease. He is the past-chair of the medical advisory board of The Myositis Association (TMA) as well as past-chair of the scientific committee of IMACS, which are the largest patient and physician groups working in the field of myositis, respectively.

Ellen Weiss connects CROs and sponsors with right-sized hybrid and remote solutions. She has spoken on the logistical support necessary for IMP delivery and dosing, sample collection, and the services provided by clinical trial research nurses that enable alternate-site visits to be carried out with the same data quality and subject safety as on-site visits. Ellen is a member of the Healthcare Businesswomen’s Association and is a volunteer for the American Society of Clinical Oncology.

Francesco Fasanella is a Process Technology Manager at Indena, Italy. His primary responsibilities, in addition to the daily supervision of pilot departments, include resource management, the implementation of new technologies, and, in collaboration with other key company figures, the management of new production projects, from the assessment of plant feasibility to the final realization of the process. Francesco holds a Master’s degree in Organic Chemistry from the University of Milan, where he collaborated as a researcher for two years in the Natural Organic Substances laboratories after completing his studies.

Luca Domenighini is a scientist specialized in the synthesis and manufacture of active pharmaceutical ingredients. Graduated at “Università degli studi di Pavia” and trained in the organic synthesis, Luca joined Indena in 2011.

He is currently working as a project leader on different CDMO projects regarding HPAPI, spacing from the development/optimization of the manufacturing process to the scale up working from grams to Kg. In his experience he’s faced all the main topics regarding the process, including the handling, synthesis purification and drying of these active substances.

Jonathan Guiter has over a decade of experience in the pharmaceutical industry, focusing on CDMO of high potent APIs (HPAPIs) and complex APIs. Jonathan is currently Business Development Manager at Indena, leading CDMO services for Europe and Asia. Before joining Indena, Jonathan managed the custom synthesis business at Zambon’s Zach System and held key roles at Safic-Alcan, overseeing API sourcing and commercialization. Jonathan began his career at GSK, synthesizing API in R&D Discovery department. He holds a Master’s degree in Chemistry from Chimie ParisTech – PSL and an engineering chemical degree from ESCOM.